Artemether is an artemisinin-derivative antimalarial most commonly formulated in fixed-dose combination with lumefantrine, the WHO-recommended first-line therapy for uncomplicated Plasmodium falciparum malaria. Simson Pharma's Artemether reference standard and impurities support QC across this globally vital antimalarial combination.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Artemether Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.